DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q4 2020$37,770,000
+36.1%
538,721
-45.5%
0.75%
+10.4%
Q3 2020$27,747,000
-19.1%
988,841
-14.7%
0.68%
-32.3%
Q2 2020$34,279,000
+49.2%
1,158,8410.0%1.00%
+36.9%
Q1 2020$22,980,000
-33.0%
1,158,8410.0%0.73%
-33.4%
Q4 2019$34,313,000
+30.2%
1,158,8410.0%1.10%
+2.0%
Q3 2019$26,352,000
-8.1%
1,158,8410.0%1.07%
+4.3%
Q2 2019$28,670,000
+1.2%
1,158,8410.0%1.03%
-5.2%
Q1 2019$28,334,000
+7.5%
1,158,8410.0%1.09%
+3.0%
Q4 2018$26,364,000
-28.5%
1,158,8410.0%1.06%
-20.1%
Q3 2018$36,874,000
-11.2%
1,158,8410.0%1.32%
-9.4%
Q2 2018$41,521,000
+8.1%
1,158,8410.0%1.46%
+9.5%
Q1 2018$38,416,000
-26.9%
1,158,841
-32.2%
1.33%
-35.6%
Q4 2017$52,530,000
+28.0%
1,709,4000.0%2.07%
+11.8%
Q3 2017$41,043,000
+43.1%
1,709,4000.0%1.85%
+20.8%
Q2 2017$28,684,000
-24.8%
1,709,4000.0%1.53%
+3.9%
Q1 2017$38,154,000
+37.5%
1,709,4000.0%1.47%
+28.9%
Q4 2016$27,744,000
+20.4%
1,709,4000.0%1.14%
+6.5%
Q3 2016$23,043,000
-44.8%
1,709,4000.0%1.07%
-34.6%
Q2 2016$41,709,000
-29.4%
1,709,4000.0%1.64%
-34.8%
Q1 2016$59,043,0001,709,4002.51%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2023
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 54,615$4,897,0002.55%
Capital Impact Advisors, LLC 130,000$9,114,0002.24%
ARK Investment Management 10,125,564$709,903,0001.89%
Nikko Asset Management Americas, Inc. 4,388,143$307,653,0001.75%
Spectrum Planning & Advisory Services Inc. 17,522$1,228,0001.32%
DDD Partners, LLC 79,527$5,576,0001.10%
Brevan Howard Capital Management LP 76,420$5,358,0001.08%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 538,721$37,770,0000.75%
DC Investments Management, LLC 3,627$254,0000.63%
Haafor (Singapore) Pte. Ltd. 4,761$334,0000.62%
View complete list of EDITAS MEDICINE INC shareholders